대규모/소규모 바이오프로세싱 시장 규모 조사 : 제품별, 워크플로우별, 규모별, 용도별, 지역별 예측(2022-2032년)

Global Large and Small Scale Bioprocessing Market is valued at approximately USD 57.08 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 14.21% over the forecast period 2024-2032. Large-scale bioprocessing involves the industrial-scale production of biopharmaceuticals and bioproducts, designed to meet the expansive demands of a broad patient population. This segment typically utilizes bioreactors with capacities ranging from thousands to tens of thousands of liters, emphasizing efficiency, automation, and cost-effectiveness. It is pivotal for the mass production of well-established biopharmaceuticals such as vaccines and monoclonal antibodies.

The Global Large and Small Scale Bioprocessing Market is driven by burgeoning demand for biopharmaceuticals, driven by an aging population and the pressing need for novel treatments, serves as a primary catalyst for large-scale bioprocessing. The scope encompasses the manufacture of vaccines, monoclonal antibodies, and therapeutic proteins to address global healthcare requirements. Additionally, continual research and development efforts in biomanufacturing introduce novel processes and techniques, creating opportunities for the large-scale production of innovative bioproducts, including cutting-edge therapies and bio-based materials. However, initial investment costs and complex regulatory environment is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Large and Small Scale Bioprocessing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, the North American region was the dominating among regional market in terms of revenue owing to factors such as robust biopharmaceutical sector and advanced technological infrastructure. The region, spearheaded by the United States, hosts major pharmaceutical and biotech entities, thereby driving demand for advanced bioprocessing solutions. Persistent research and development initiatives foster innovation, enhancing single-use systems, bioreactors, and analytical tools. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

• Thermo Fisher Scientific
• Lonza Group
• Merck & Co., Inc.
• GE Healthcare
• Danaher Corporation
• Pall Corporation
• Eppendorf AG
• Fujifilm Diosynth Biotechnologies
• Boehringer Ingelheim
• ABEC
• Brammer Bio
• CellGenix
• Novasep
• MilliporeSigma
• AB Sciex

The detailed segments and sub-segment of the market are explained below:

By Product:

• Filtration Assemblies
• Bioreactors/Fermenters
• Cell Culture Products
• Others

By Workflow:

• Downstream Processing
• Fermentation
• Upstream Processing

By Scale:

• Small Scale
• Industrial Scale

By Application:

• Environmental Aids
• Biopharmaceuticals
• Speciality Industrial Chemicals
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Large and Small Scale Bioprocessing Market Executive Summary

• 1.1. Global Large and Small Scale Bioprocessing Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Workflow
  • 1.3.3. By Scale
  • 1.3.4. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Large and Small Scale Bioprocessing Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Large and Small Scale Bioprocessing Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Demand for Biopharmaceuticals
  • 3.1.2. Aging Population and Need for Novel Treatments
  • 3.1.3. Research and Development in Biomanufacturing
• 3.2. Market Challenges
  • 3.2.1. High Initial Investment Costs
  • 3.2.2. Complex Regulatory Environment
• 3.3. Market Opportunities
  • 3.3.1. Advancements in Bioprocessing Technologies
  • 3.3.2. Emerging Markets
  • 3.3.3. Development of Innovative Bioproducts

Chapter 4. Global Large and Small Scale Bioprocessing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Large and Small Scale Bioprocessing Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Large and Small Scale Bioprocessing Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Filtration Assemblies
  • 5.2.2. Bioreactors/Fermenters
  • 5.2.3. Cell Culture Products
  • 5.2.4. Others

Chapter 6. Global Large and Small Scale Bioprocessing Market Size & Forecasts by Workflow 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Large and Small Scale Bioprocessing Market: Workflow Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Downstream Processing
  • 6.2.2. Fermentation
  • 6.2.3. Upstream Processing

Chapter 7. Global Large and Small Scale Bioprocessing Market Size & Forecasts by Scale 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Large and Small Scale Bioprocessing Market: Scale Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Small Scale
  • 7.2.2. Industrial Scale

Chapter 8. Global Large and Small Scale Bioprocessing Market Size & Forecasts by Application 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Large and Small Scale Bioprocessing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 8.2.1. Environmental Aids
  • 8.2.2. Biopharmaceuticals
  • 8.2.3. Speciality Industrial Chemicals
  • 8.2.4. Others

Chapter 9. Global Large and Small Scale Bioprocessing Market Size & Forecasts by Region 2022-2032

• 9.1. North America Large and Small Scale Bioprocessing Market
  • 9.1.1. U.S. Large and Small Scale Bioprocessing Market
    • 9.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 9.1.1.2. Workflow breakdown size & forecasts, 2022-2032
    • 9.1.1.3. Scale breakdown size & forecasts, 2022-2032
    • 9.1.1.4. Application breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Large and Small Scale Bioprocessing Market
• 9.2. Europe Large and Small Scale Bioprocessing Market
  • 9.2.1. U.K. Large and Small Scale Bioprocessing Market
  • 9.2.2. Germany Large and Small Scale Bioprocessing Market
  • 9.2.3. France Large and Small Scale Bioprocessing Market
  • 9.2.4. Spain Large and Small Scale Bioprocessing Market
  • 9.2.5. Italy Large and Small Scale Bioprocessing Market
  • 9.2.6. Rest of Europe Large and Small Scale Bioprocessing Market
• 9.3. Asia-Pacific Large and Small Scale Bioprocessing Market
  • 9.3.1. China Large and Small Scale Bioprocessing Market
  • 9.3.2. India Large and Small Scale Bioprocessing Market
  • 9.3.3. Japan Large and Small Scale Bioprocessing Market
  • 9.3.4. Australia Large and Small Scale Bioprocessing Market
  • 9.3.5. South Korea Large and Small Scale Bioprocessing Market
  • 9.3.6. Rest of Asia Pacific Large and Small Scale Bioprocessing Market
• 9.4. Latin America Large and Small Scale Bioprocessing Market
  • 9.4.1. Brazil Large and Small Scale Bioprocessing Market
  • 9.4.2. Mexico Large and Small Scale Bioprocessing Market
  • 9.4.3. Rest of Latin America Large and Small Scale Bioprocessing Market
• 9.5. Middle East & Africa Large and Small Scale Bioprocessing Market
  • 9.5.1. Saudi Arabia Large and Small Scale Bioprocessing Market
  • 9.5.2. South Africa Large and Small Scale Bioprocessing Market
  • 9.5.3. Rest of Middle East & Africa Large and Small Scale Bioprocessing Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Thermo Fisher Scientific
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. Lonza Group
  • 10.3.3. Merck & Co., Inc.
  • 10.3.4. GE Healthcare
  • 10.3.5. Danaher Corporation
  • 10.3.6. Pall Corporation
  • 10.3.7. Eppendorf AG
  • 10.3.8. Fujifilm Diosynth Biotechnologies
  • 10.3.9. Boehringer Ingelheim
  • 10.3.10. ABEC
  • 10.3.11. Brammer Bio
  • 10.3.12. CellGenix
  • 10.3.13. Novasep
  • 10.3.14. MilliporeSigma
  • 10.3.15. AB Sciex

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes